Thrivent Financial for Lutherans’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-214,983
Closed -$10.8M 2512
2023
Q2
$10.8M Sell
214,983
-11,196
-5% -$596K 0.02% 620
2023
Q1
$12.3M Buy
226,179
+4,842
+2% +$283K 0.03% 557
2022
Q4
$13.8M Sell
221,337
-219,730
-50% -$14.6M 0.04% 511
2022
Q3
$31.1M Sell
441,067
-22,238
-5% -$1.53M 0.09% 279
2022
Q2
$26.3M Sell
463,305
-7,350
-2% -$403K 0.07% 337
2022
Q1
$29.5M Sell
470,655
-480
-0.1% -$25.9K 0.06% 350
2021
Q4
$26.4M Buy
471,135
+80,068
+20% +$4.89M 0.05% 393
2021
Q3
$25.5M Buy
391,067
+11,249
+3% +$768K 0.05% 393
2021
Q2
$24.1M Buy
379,818
+39,321
+12% +$2.32M 0.05% 406
2021
Q1
$20.4M Buy
340,497
+23,728
+7% +$1.29M 0.04% 439
2020
Q4
$15.8M Buy
316,769
+33,979
+12% +$1.6M 0.04% 511
2020
Q3
$14.4M Sell
282,790
-77,388
-21% -$3.23M 0.04% 498
2020
Q2
$12.6M Sell
360,178
-128,483
-26% -$4.43M 0.04% 495
2020
Q1
$12.4M Buy
488,661
+1,336
+0.3% +$39.7K 0.04% 443
2019
Q4
$13.5M Buy
487,325
+289,495
+146% +$6.91M 0.04% 488
2019
Q3
$5.33M Buy
+197,830
New +$6.89M 0.02% 673

Other funds holding AXNX

Thrivent Financial for Lutherans's AXNX Position: Q3 2023 in Review

Thrivent Financial for Lutherans sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2023, closing a stake of 214,983 shares — an estimated $10.8M sold.

Thrivent Financial for Lutherans first reported a position in AXNX in Q3 2019 and held it in 16 quarters. The position peaked at $31.1M in Q3 2022. 221 funds tracked by Wall St. Rank hold AXNX as of Q3 2023.

  • Thrivent Financial for Lutherans reported no remaining Axonics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 214,983 Axonics, Inc. Common Stock shares in Q3 2023, an estimated $10.8M.
  • Thrivent Financial for Lutherans first reported a position in Axonics, Inc. Common Stock in Q3 2019 and held it in 16 quarters.
  • Thrivent Financial for Lutherans's Axonics, Inc. Common Stock position peaked at $31.1M in Q3 2022.
  • 221 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2023.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2023, filed 14 Nov 2023.